Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy.

Arons E, Suntum T, Stetler-Stevenson M, Kreitman RJ.

Blood. 2009 Nov 19;114(21):4687-95. doi: 10.1182/blood-2009-01-201731. Epub 2009 Sep 10.

2.

Molecular variant of hairy cell leukemia with poor prognosis.

Arons E, Kreitman RJ.

Leuk Lymphoma. 2011 Jun;52 Suppl 2:99-102. doi: 10.3109/10428194.2011.565841.

PMID:
21599610
3.

Hairy cell leukemias with unmutated IGHV genes define the minor subset refractory to single-agent cladribine and with more aggressive behavior.

Forconi F, Sozzi E, Cencini E, Zaja F, Intermesoli T, Stelitano C, Rigacci L, Gherlinzoni F, Cantaffa R, Baraldi A, Gallamini A, Zaccaria A, Pulsoni A, Gobbi M, Tassi M, Raspadori D, Leoncini L, Rinaldi A, Sabattini E, Bertoni F, Pileri SA, Lauria F.

Blood. 2009 Nov 19;114(21):4696-702. doi: 10.1182/blood-2009-03-212449. Epub 2009 Aug 10.

4.

Impact of telomere length on survival in classic and variant hairy cell leukemia.

Arons E, Zhou H, Edelman DC, Gomez A, Steinberg SM, Petersen D, Wang Y, Meltzer PS, Kreitman RJ.

Leuk Res. 2015 Dec;39(12):1360-6. doi: 10.1016/j.leukres.2015.09.015. Epub 2015 Sep 24.

5.

2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in Poland.

Robak T, Błasińska-Morawiec M, Błoński J, Hellmann A, Hałaburda K, Konopka L, Kotlarek-Haus S, Potoczek S, Hansz J, Dmoszyńska A, Urasiński I, Zdziarska B, Dwilewicz-Trojaczek J, Hołowiecki J, Skotnicki AB.

Eur J Haematol. 1999 Jan;62(1):49-56.

PMID:
9918312
6.

Treatment of hairy cell leukemia-variant with cladribine.

Tetreault SA, Robbins BA, Saven A.

Leuk Lymphoma. 1999 Oct;35(3-4):347-54.

PMID:
10706459
7.

Cladribine with immediate rituximab for the treatment of patients with variant hairy cell leukemia.

Kreitman RJ, Wilson W, Calvo KR, Arons E, Roth L, Sapolsky J, Zhou H, Raffeld M, Stetler-Stevenson M.

Clin Cancer Res. 2013 Dec 15;19(24):6873-81. doi: 10.1158/1078-0432.CCR-13-1752. Epub 2013 Nov 25.

8.

Update on the biology and treatment options for hairy cell leukemia.

Jain P, Pemmaraju N, Ravandi F.

Curr Treat Options Oncol. 2014 Jun;15(2):187-209. doi: 10.1007/s11864-014-0285-5. Review.

9.

Cladribine in hairy cell leukemia.

Belani R, Saven A.

Hematol Oncol Clin North Am. 2006 Oct;20(5):1109-23. Review.

PMID:
16990111
10.

Hairy cell leukaemia-variant: Disease features and treatment.

Matutes E, Martínez-Trillos A, Campo E.

Best Pract Res Clin Haematol. 2015 Dec;28(4):253-63. doi: 10.1016/j.beha.2015.09.002. Epub 2015 Oct 8. Review.

PMID:
26614904
11.

Evidence of canonical somatic hypermutation in hairy cell leukemia.

Arons E, Roth L, Sapolsky J, Suntum T, Stetler-Stevenson M, Kreitman RJ.

Blood. 2011 May 5;117(18):4844-51. doi: 10.1182/blood-2010-11-316737. Epub 2011 Mar 2.

12.

Long-term durable remission by cladribine followed by rituximab in patients with hairy cell leukaemia: update of a phase II trial.

Chihara D, Kantarjian H, O'Brien S, Jorgensen J, Pierce S, Faderl S, Ferrajoli A, Poku R, Jain P, Thompson P, Brandt M, Luthra R, Burger J, Keating M, Ravandi F.

Br J Haematol. 2016 Sep;174(5):760-6. doi: 10.1111/bjh.14129. Epub 2016 Jun 15.

13.

Clinical characteristics and long-term outcome of young hairy cell leukemia patients treated with cladribine: a single-institution series.

Rosenberg JD, Burian C, Waalen J, Saven A.

Blood. 2014 Jan 9;123(2):177-83. doi: 10.1182/blood-2013-06-508754. Epub 2013 Nov 5.

14.

[Treatment of hairy cell leukemia with cladribine].

Aurer I, Mitrović Z, Kovacević-Metelko J, Radman I, Basić-Kinda S, Gjadrov-Kuvezdić K, Jakić-Razumović J, Dubravcić K, Ries S, Nola M, Zupancic-Salek S, Labar B.

Lijec Vjesn. 2007 Mar-Apr;129(3-4):80-3. Croatian.

PMID:
17557550
15.

Both variant and IGHV4-34-expressing hairy cell leukemia lack the BRAF V600E mutation.

Xi L, Arons E, Navarro W, Calvo KR, Stetler-Stevenson M, Raffeld M, Kreitman RJ.

Blood. 2012 Apr 5;119(14):3330-2. doi: 10.1182/blood-2011-09-379339. Epub 2011 Dec 30.

16.

Molecular evaluation of clonal remission in hairy cell leukemia patients treated with 2-chlorodeoxyadenosine.

di Celle PF, Reato G, Raspadori D, Carbone A, Rondelli D, Lauria F, Foà R.

Leuk Lymphoma. 1994;14 Suppl 1:139-42.

PMID:
7820046
17.

Long-term follow-up of patients with hairy cell leukemia after cladribine treatment.

Saven A, Burian C, Koziol JA, Piro LD.

Blood. 1998 Sep 15;92(6):1918-26.

18.
19.

Hairy cell leukemia: an elusive but treatable disease.

Wanko SO, de Castro C.

Oncologist. 2006 Jul-Aug;11(7):780-9.

Supplemental Content

Support Center